Higher c-MYC Expression Is Associated with Ixazomib-Lenalidomide-Dexamethasone (IRd) Progression-Free Survival (PFS) Benefit Versus Placebo-Rd: Biomarker Analysis of the Phase 3 Tourmaline-MM1 Study in Relapsed/ Refractory Multiple Myeloma (RRMM)

被引：4

作者：

Di Bacco, Alessandra ^{[1
]}

Bahlis, Nizar J. ^{[2
,3
]}

Munshi, Nikhil C. ^{[4
]}

Avet-Loiseau, Herve ^{[5
]}

Masszi, Tamas ^{[6
]}

Viterbo, Luisa ^{[7
]}

Pour, Ludek ^{[8
]}

Ganly, Peter ^{[9
]}

Cavo, Michele ^{[10
]}

Langer, Christian ^{[11
]}

Kumar, Shaji ^{[12
]}

Rajkumar, S. Vincent ^{[12
]}

Berg, Deborah ^{[1
]}

Lin, Jianchang ^{[1
]}

Li, Bin ^{[1
]}

Badola, Sunita ^{[1
]}

Shen, Lei ^{[1
]}

Zhang, Jacob ^{[1
]}

Wang, Ling ^{[1
]}

Esseltine, Dixie-Lee ^{[1
]}

Luptakova, Katarina ^{[1
]}

de Velde, Helgi van ^{[1
]}

Richardson, Paul G. ^{[13
]}

Moreau, Philippe ^{[14
]}

机构：

[1] Millennium Pharmaceut Inc, Cambridge, MA USA

[2] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[3] Univ Calgary, Calgary, AB, Canada

[4] Dana Farber Canc Inst, Hematol Oncol, Boston, MA 02115 USA

[5] IUC Oncopole, Hematol, Toulouse, France

[6] St Istvan & St Laszlo Hosp Budapest, Dept Haematol & Stem Cell Transplant, Budapest, Hungary

[7] Entidade Publ Empresarial IPOPFG, EPE, Inst Portugues Oncol Porto Francis, Porto, Portugal

[8] Univ Hosp Brno, Hematol & Oncol, Brno, Czech Republic

[9] Christchurch Hosp, Dept Haematol, Christchurch, New Zealand

[10] Univ Bologna, Seragnoli Inst Hematol, Bologna, Italy

[11] Univ Hosp Ulm, Ulm, Germany

[12] Mayo Clin, Div Hematol, Rochester, MN 55905 USA

[13] Dana Farber Canc Inst, Boston, MA 02115 USA

[14] Univ Hosp Hotel Dieu, Hematol, Nantes, France

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.243.243

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

243

引用

页数：7